BRIDGEWATER, N.J., Sept. 9, 2020 /PRNewswire/ -- Insmed
Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a
mission to transform the lives of patients with serious and rare
diseases, today announced that management will present at the
following virtual investor conferences:
- The H.C. Wainwright Annual Global Investment Conference on
Monday, September 14, 2020 at
9:30 a.m. ET
- The Morgan Stanley Annual Global Healthcare Conference on
Tuesday, September 15, 2020 at
9:30 a.m. ET
- The Cantor Virtual Healthcare Conference on Thursday, September 17, 2020 at 9:20 a.m. ET
Each presentation will be webcast live and can be accessed by
visiting the investor relations section of the company's website at
www.insmed.com. Each webcast will be archived for a period of 30
days following the conclusion of each live event.
About Insmed
Insmed Incorporated is a global biopharmaceutical company on a
mission to transform the lives of patients with serious and rare
diseases. Insmed's first commercial product, ARIKAYCE® (amikacin
liposome inhalation suspension), is the first and only therapy
approved in the United States for the treatment of
refractory Mycobacterium avium complex (MAC) lung
disease as part of a combination antibacterial drug regimen for
adult patients with limited or no alternative treatment options.
MAC lung disease is a chronic, debilitating condition that can
cause severe and permanent lung damage. Insmed is also advancing
brensocatib, a novel oral reversible inhibitor of dipeptidyl
peptidase 1 with therapeutic potential in bronchiectasis and other
inflammatory diseases, and treprostinil palmitil, an inhaled
formulation of a treprostinil prodrug that may offer a
differentiated product profile for rare pulmonary disorders,
including pulmonary arterial hypertension. For more information,
visit www.insmed.com.
Contact:
Investors:
Argot Partners
Laura Perry or Heather Savelle
(212) 600-1902
insmed@argotpartners.com
Media:
Mandy Fahey
Senior Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/insmed-to-present-at-three-september-conferences-301126868.html
SOURCE Insmed Incorporated